Novartis keeps a close eye on gene therapy with Vedere Bio buyAlready a major player in gene therapy, Novartis has swooped on US startup Vedere Bio in a $280 Share XNovartis keeps a close eye on gene therapy with Vedere Bio buyhttps://pharmaphorum.com/news/novartis-keeps-a-close-eye-on-gene-therapy-with-vedere-bio-buy/
Gilead Q3 revenue rise bolstered by $873m Veklury salesGilead Sciences is the first and so far only company to claim FDA approval for a COVID-19 treatment Share XGilead Q3 revenue rise bolstered by $873m Veklury saleshttps://pharmaphorum.com/news/gilead-q3-revenue-rise-bolstered-by-873m-veklury-sales/
BMS joins forces with insitro to develop neurodegenerative treatmentsinsitro has landed another big biopharma partnership, signing a five-year collaboration with Bristol Myers Sqibb to develop therapies Share XBMS joins forces with insitro to develop neurodegenerative treatmentshttps://pharmaphorum.com/news/bms-joins-forces-with-insitro-to-develop-neurodegenerative-treatments/
What can we learn from women’s health data?Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Share XWhat can we learn from women’s health data?https://pharmaphorum.com/views-analysis-digital/what-can-we-learn-from-womens-health-data/
10 Tips for Digital Asset Management SuccessGiven the recent rise in digital engagement and the drastic increase in digital content, it’s now essential that Share X10 Tips for Digital Asset Management Successhttps://pharmaphorum.com/whitepapers/10-tips-for-digital-asset-management-success/
Pharma 2030: Will payers fund more preventive care programmes?Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake. A new Share XPharma 2030: Will payers fund more preventive care programmes?https://pharmaphorum.com/patients/pharma-2030-will-payers-fund-more-preventive-care-programmes/
The right people and the right environment for innovative commsMike Dixon, CEO of the Healthcare Communications Association, discusses the biggest challenges facing the sector during and after Share XThe right people and the right environment for innovative commshttps://deep-dive.pharmaphorum.com/magazine/communications-2020/the-right-people-and-the-right-environment-for-innovative-comms/
Developing enhanced digital content to increase physician engagementWith in-person scientific congresses an impossibility for the foreseeable future, researchers and publishers have to adapt how they Share XDeveloping enhanced digital content to increase physician engagementhttps://deep-dive.pharmaphorum.com/magazine/communications-2020/developing-enhanced-digital-content-to-increase-physician-engagement/
Responding to dynamic shifts in value communicationsOPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means Share XResponding to dynamic shifts in value communicationshttps://deep-dive.pharmaphorum.com/magazine/communications-2020/responding-to-dynamic-shifts-in-value-communications/
Introducing the new NIHR National Patient Recruitment Centres Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
How to win with a multichannel approach in pharma Share XHow to win with a multichannel approach in pharmahttps://pharmaphorum.com/digital/multichannel-approach-pharma-viseven/
Accelerating pharma’s digital IQ as customer engagement evolves Share XAccelerating pharma’s digital IQ as customer engagement evolveshttps://pharmaphorum.com/digital/veeva-customer-engagement-webinar/
10 Tips for Digital Asset Management SuccessGiven the recent rise in digital engagement and the drastic increase in digital content, it’s now essential that Share X10 Tips for Digital Asset Management Successhttps://pharmaphorum.com/whitepapers/10-tips-for-digital-asset-management-success/
Transformational value – preparing for a decade of radical changeThe pharmaceutical industry is at an inflection point, where ground-breaking innovation must be translated into transformational value for Share XTransformational value – preparing for a decade of radical changehttps://pharmaphorum.com/whitepapers/preparing-for-a-decade-of-radical-change-in-pharma-transformational-value/
COVID-19’s lasting impact on digital communication in healthcareThe ongoing digital transformation of the healthcare and pharmaceutical industries has been greatly accelerated during the coronavirus pandemic. Share XCOVID-19’s lasting impact on digital communication in healthcarehttps://pharmaphorum.com/whitepapers/covid-19s-lasting-impact-on-digital-communication-in-healthcare/
A new approach to mental health – the Health Heroes podcast Share XA new approach to mental health – the Health Heroes podcasthttps://pharmaphorum.com/podcast/mental-health-covid-19-telehealth/
Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum podcast Share XGitte Aabo on telemedicine and GN Hearing: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gitte-aabo-telemedicine-gn-hearing
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse Lab Share XThe Alderley Park Discovery Podcast: COVID testing and the Lighthouse Labhttps://pharmaphorum.com/podcast/alderley-park-discovery-podcast-lighthouse-lab/
SMi’s 3D Cell Culture Conference 2021 – Speakers Announced Share XSMi’s 3D Cell Culture Conference 2021 – Speakers Announcedhttps://pharmaphorum.com/partner-content/smis-3d-cell-culture-conference-2021-speakers-announced/
J+D FORECASTING LAUNCHES INTELLIGENT DATA Share XJ+D FORECASTING LAUNCHES INTELLIGENT DATAhttps://pharmaphorum.com/partner-content/jd-forecasting-launches-intelligent-data/
Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done Share XRetired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Donehttps://pharmaphorum.com/partner-content/retired-nfl-linebacker-overcomes-adhd-invests-in-mental-health-platform-done/
Exclusive Pharma Microbiology interview with Maria Jose Lopez Barragan, formerly at FDA Share XExclusive Pharma Microbiology interview with Maria Jose Lopez Barragan, formerly at FDAhttps://pharmaphorum.com/partner-content/exclusive-pharma-microbiology-interview-with-maria-jose-lopez-barragan-formerly-at-fda/
Prescient Announces Recent Appointments to the Senior Advisory Team Share XPrescient Announces Recent Appointments to the Senior Advisory Teamhttps://pharmaphorum.com/partner-content/prescient-announces-recent-appointments-to-the-senior-advisory-team/
Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team Share XPrescient Intelligence & Insight Announces Recent Appointments to the Senior Teamhttps://pharmaphorum.com/partner-content/prescient-intelligence-insight-announces-recent-appointments-to-the-senior-team-2/
